Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease
Background Fibrates have renal toxicity limiting their use in subjects with chronic kidney disease (CKD). However, pemafibrate has fewer toxic effects on renal function. In the present analysis, we evaluated the effects of pemafibrate on the renal function of diabetic subjects with or without CKD in...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Diabetes Association
2024-05-01
|
| シリーズ: | Diabetes & Metabolism Journal |
| 主題: | |
| オンライン・アクセス: | http://www.e-dmj.org/upload/pdf/dmj-2023-0370.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
